<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:56:01Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9639834" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9639834</identifier>
        <datestamp>2022-11-08</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9639834</article-id>
              <article-id pub-id-type="pmcid">PMC9639834</article-id>
              <article-id pub-id-type="pmc-uid">9639834</article-id>
              <article-id pub-id-type="pmid">36342940</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0277312</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-22-13097</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                      <subj-group>
                        <subject>Hypertension</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical Microbiology</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Immunodeficiency Viruses</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pathology and Laboratory Medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Immunodeficiency Viruses</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral Pathogens</subject>
                        <subj-group>
                          <subject>Immunodeficiency Viruses</subject>
                          <subj-group>
                            <subject>HIV</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Immunodeficiency Viruses</subject>
                        <subj-group>
                          <subject>HIV</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and life sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>RNA viruses</subject>
                        <subj-group>
                          <subject>Retroviruses</subject>
                          <subj-group>
                            <subject>Lentivirus</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Microbiology</subject>
                    <subj-group>
                      <subject>Medical Microbiology</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Retroviruses</subject>
                            <subj-group>
                              <subject>Lentivirus</subject>
                              <subj-group>
                                <subject>HIV</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Pathology and Laboratory Medicine</subject>
                    <subj-group>
                      <subject>Pathogens</subject>
                      <subj-group>
                        <subject>Microbial Pathogens</subject>
                        <subj-group>
                          <subject>Viral Pathogens</subject>
                          <subj-group>
                            <subject>Retroviruses</subject>
                            <subj-group>
                              <subject>Lentivirus</subject>
                              <subj-group>
                                <subject>HIV</subject>
                              </subj-group>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Organisms</subject>
                    <subj-group>
                      <subject>Viruses</subject>
                      <subj-group>
                        <subject>Viral Pathogens</subject>
                        <subj-group>
                          <subject>Retroviruses</subject>
                          <subj-group>
                            <subject>Lentivirus</subject>
                            <subj-group>
                              <subject>HIV</subject>
                            </subj-group>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Economics</subject>
                    <subj-group>
                      <subject>Finance</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Engineering and Technology</subject>
                  <subj-group>
                    <subject>Transportation</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                      <subj-group>
                        <subject>Hypertension</subject>
                        <subj-group>
                          <subject>Hypertensive Disorders in Pregnancy</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Women's Health</subject>
                    <subj-group>
                      <subject>Maternal Health</subject>
                      <subj-group>
                        <subject>Pregnancy</subject>
                        <subj-group>
                          <subject>Hypertensive Disorders in Pregnancy</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Women's Health</subject>
                    <subj-group>
                      <subject>Obstetrics and Gynecology</subject>
                      <subj-group>
                        <subject>Pregnancy</subject>
                        <subj-group>
                          <subject>Hypertensive Disorders in Pregnancy</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and health sciences</subject>
                  <subj-group>
                    <subject>Diagnostic medicine</subject>
                    <subj-group>
                      <subject>HIV diagnosis and management</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Vascular Medicine</subject>
                    <subj-group>
                      <subject>Blood Pressure</subject>
                      <subj-group>
                        <subject>Hypertension</subject>
                        <subj-group>
                          <subject>Secondary Hypertension</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda: A randomized controlled trial</article-title>
                <alt-title alt-title-type="running-head">Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8913-1602</contrib-id>
                  <name>
                    <surname>Hickey</surname>
                    <given-names>Matthew D.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5594-0310</contrib-id>
                  <name>
                    <surname>Owaraganise</surname>
                    <given-names>Asiphas</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sang</surname>
                    <given-names>Norton</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Opel</surname>
                    <given-names>Fredrick J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Mugoma</surname>
                    <given-names>Erick Wafula</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ayieko</surname>
                    <given-names>James</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0265-3174</contrib-id>
                  <name>
                    <surname>Kabami</surname>
                    <given-names>Jane</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chamie</surname>
                    <given-names>Gabriel</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9532-5710</contrib-id>
                  <name>
                    <surname>Kakande</surname>
                    <given-names>Elijah</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Petersen</surname>
                    <given-names>Maya L.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3730-410X</contrib-id>
                  <name>
                    <surname>Balzer</surname>
                    <given-names>Laura B.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kamya</surname>
                    <given-names>Moses R.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="aff005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Havlir</surname>
                    <given-names>Diane V.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Division of HIV, Infectious Disease, &amp; Global Medicine, University of California, San Francisco, CA, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Infectious Diseases Research Collaboration, Kampala, Uganda</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Kenya Medical Research Institute, Nairobi, Kenya</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>School of Public Health, University of California, Berkeley, CA, United States of America</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>School of Medicine, Makerere University, Kampala, Uganda</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Mugo</surname>
                    <given-names>Peter M.</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>KEMRI Wellcome Trust Research Programme, KENYA</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>Matt.hickey@ucsf.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>7</day>
                <month>11</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>17</volume>
              <issue>11</issue>
              <elocation-id>e0277312</elocation-id>
              <history>
                <date date-type="received">
                  <day>24</day>
                  <month>5</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>24</day>
                  <month>10</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2022 Hickey et al</copyright-statement>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Hickey et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0277312.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Background</title>
                  <p>Fewer than 10% of people with hypertension in sub-Saharan Africa are diagnosed, linked to care, and achieve hypertension control. We hypothesized that a one-time financial incentive and phone call reminder for missed appointments would increase linkage to hypertension care following community-based screening in rural Uganda and Kenya.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods</title>
                  <p>In a randomized controlled trial, we conducted community-based hypertension screening and enrolled adults ≥25 years with blood pressure ≥140/90 mmHg on three measures; we excluded participants with known hypertension or hypertensive emergency. The intervention was transportation reimbursement upon linkage (~$5 USD) and up to three reminder phone calls for those not linking within seven days. Control participants received a clinic referral only. Outcomes were linkage to hypertension care within 30 days (primary) and hypertension control &lt;140/90 mmHg measured in all participants at 90 days (secondary). We used targeted minimum loss-based estimation to compute adjusted risk ratios (aRR).</p>
                </sec>
                <sec id="sec003">
                  <title>Results</title>
                  <p>We screened 1,998 participants, identifying 370 (18.5%) with uncontrolled hypertension and enrolling 199 (100 control, 99 intervention). Reasons for non-enrollment included prior hypertension diagnosis (n = 108) and hypertensive emergency (n = 32). Participants were 60% female, median age 56 (range 27–99); 10% were HIV-positive and 42% had baseline blood pressure ≥160/100 mmHg. Linkage to care within 30 days was 96% in intervention and 66% in control (aRR 1.45, 95%CI 1.25–1.68). Hypertension control at 90 days was 51% intervention and 41% control (aRR 1.22, 95%CI 0.92–1.66).</p>
                </sec>
                <sec id="sec004">
                  <title>Conclusion</title>
                  <p>A one-time financial incentive and reminder call for missed visits resulted in a 30% absolute increase in linkage to hypertension care following community-based screening. Financial incentives can improve the critical step of linkage to care for people newly diagnosed with hypertension in the community.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
                      <institution>National Institute of Allergy and Infectious Diseases</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U01-AI150510</award-id>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
                      <institution>National Institute of Allergy and Infectious Diseases</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>T32-AI060530</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8913-1602</contrib-id>
                    <name>
                      <surname>Hickey</surname>
                      <given-names>Matthew D.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000050</institution-id>
                      <institution>National Heart, Lung, and Blood Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K23HL162578</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8913-1602</contrib-id>
                    <name>
                      <surname>Hickey</surname>
                      <given-names>Matthew D.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>The study was supported by a grant from the National Institutes of Health (U01-AI150510; Multiple-PI award to MLP, MRK, DVH). MDH was supported by grants from the National Institute of Allergy and Infectious Diseases (T32-AI060530) and the National Heart, Lung, and Blood Institute (K23HL162578). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="5"/>
                <page-count count="15"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>Data cannot be shared publicly because this study was conducted with approval from the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU), which requires that data from studies (including de-identified data) are released only after they have provided written approval for additional analyses. A complete de-identified dataset sufficient to reproduce the study findings will be made available upon written request after approval from SERU. To request these data, please contact <email>douglas.black@ucsf.edu</email> (Coordinator, SEARCH Scientific Committee).</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>Data cannot be shared publicly because this study was conducted with approval from the Kenya Medical Research Institute (KEMRI) Scientific and Ethics Review Unit (SERU), which requires that data from studies (including de-identified data) are released only after they have provided written approval for additional analyses. A complete de-identified dataset sufficient to reproduce the study findings will be made available upon written request after approval from SERU. To request these data, please contact <email>douglas.black@ucsf.edu</email> (Coordinator, SEARCH Scientific Committee).</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>Hypertension is the largest driver of morbidity and mortality globally and can be treated with low-cost, readily available medications; however, less than 10% of people with hypertension in sub-Saharan Africa are diagnosed, linked to care, and have controlled hypertension [<xref rid="pone.0277312.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0277312.ref004" ref-type="bibr">4</xref>]. Community-based diagnosis and linkage to care are critical steps to improving hypertension control in sub-Saharan Africa, however, linkage to care following diagnosis has not surpassed 50% in several studies [<xref rid="pone.0277312.ref005" ref-type="bibr">5</xref>–<xref rid="pone.0277312.ref007" ref-type="bibr">7</xref>].</p>
              <p>High transportation costs, long distances from clinic, opportunity costs associated with missed work, and medication costs may all contribute to low rates of linkage to care [<xref rid="pone.0277312.ref008" ref-type="bibr">8</xref>–<xref rid="pone.0277312.ref010" ref-type="bibr">10</xref>]. Lack of awareness of the consequences of hypertension or competing priorities may also reduce motivation to seek hypertension care [<xref rid="pone.0277312.ref011" ref-type="bibr">11</xref>]. Incentives may address both financial barriers and provide extrinsic motivation to overcome initial barriers to engaging with hypertension care. Promising findings from a prior single-arm pilot study showed very high levels of linkage to care with a small conditional financial incentive at a single site in Uganda [<xref rid="pone.0277312.ref012" ref-type="bibr">12</xref>].</p>
              <p>Though literature on incentives for linkage to hypertension care in sub-Saharan Africa is limited, there is evidence from the HIV literature that financial incentives are effective for improving HIV testing and to a lesser extent linkage to HIV care [<xref rid="pone.0277312.ref013" ref-type="bibr">13</xref>]. McNairy et al. showed that a combination intervention including a nonfinancial incentive (mobile airtime) increased joint linkage and retention in care after 12 months following a new HIV diagnosis [<xref rid="pone.0277312.ref014" ref-type="bibr">14</xref>]. We have also shown high levels of linkage to HIV care following community-based screening with a combination intervention including introduction to a clinic staff member, provision of a “hot line” to answer questions about linkage, a small transportation reimbursement conditional upon linkage, and reminder calls for missed linkage appointments [<xref rid="pone.0277312.ref015" ref-type="bibr">15</xref>].</p>
              <p>Our study was motivated by the very low levels of linkage to hypertension care seen in other studies of hypertension linkage interventions in sub-Saharan Africa to date and the promising data from the HIV literature on effectiveness of one-time incentives for improving linkage to care. We conducted a randomized controlled trial to test the hypothesis that a one-time financial incentive and phone call reminder for missed appointments would increase linkage to hypertension care following community-based screening in rural Uganda and Kenya.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec006">
              <title>Methods</title>
              <sec id="sec007">
                <title>Setting and participants</title>
                <p>Between April and June 2021, we conducted community-based hypertension screening in two rural communities in western Kenya and one rural community in southwestern Uganda. A study nurse and local lay health workers conducted the screening at central locations in the community (e.g. markets, places of worship, schools) and through household screening when COVID-19 measures precluded screening at community gathering points.</p>
                <p>Participants were eligible if they were ≥25 years of age with elevated blood pressure (BP) on community-based screening (systolic blood pressure [SBP] ≥140 mmHg or diastolic blood pressure [DBP] ≥90 mmHg on each of three measurements performed by a trained study nurse using standardized procedures). BP was measured once using an automated BP machine after the participant had been seated for five minutes; those with SBP ≥140 or DBP ≥90 mmHg had two additional measurements taken at 1–2 minute intervals. Participants were excluded if they had a prior known diagnosis of hypertension, current pregnancy, or hypertensive emergency (BP ≥180/110 mmHg and signs/symptoms of target organ damage). Persons with a known diagnosis of hypertension were excluded because the intervention was designed to evaluate first-time linkage to hypertension care, rather than re-engagement. Pregnant women with hypertension or those with hypertensive emergency were immediately transported to a health facility for further management. Those with known hypertension were counseled on risks of untreated hypertension and referred to re-engage in hypertension care if needed. The study received Institutional Review Board approval from Makerere University, the Kenya Medical Research Institute, and the University of California San Francisco. Participants provided written informed consent prior to study participation. The study is registered at ClincialTrials.gov (NCT04810650).</p>
              </sec>
              <sec id="sec008">
                <title>Study design and procedures</title>
                <p>We conducted an individually randomized controlled trial of a one-time financial incentive and phone reminder calls to facilitate linkage to hypertension care among eligible participants with uncontrolled hypertension. Eligible participants were randomized to the intervention or control by selecting a sequentially numbered scratch card, revealing the arm only when scratched by the participant. The computer-generated randomization sequence was stratified on site and sex and implemented with a stratified block design with random block sizes of 2 and 4. Participants were not blinded to the randomization arm, but the study statistician (LBB) was blinded until trial completion and analysis. Based on a two-sample test for proportions, we estimated 100 participants/arm would provide 80% power to detect a 20% absolute increase in the primary outcome of linkage within 30 days from 50% in the control.</p>
                <p>All participants received post-test counseling and were scheduled for an initial hypertension care visit at a nearby government health facility within three days if BP ≥160/100mmHg and within seven days if BP was 140-159/90-99. Intervention participants received a transportation voucher and were informed that the voucher was redeemable for ~$5 USD upon linkage to hypertension care. If intervention participants did not link to care by their scheduled appointment date, they received up to three phone call attempts to encourage linkage. Control participants did not receive a linkage incentive or follow-up phone calls.</p>
                <p>Hypertension care was delivered at Ministry of Health clinics within each community using country standard hypertension guidelines [<xref rid="pone.0277312.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0277312.ref017" ref-type="bibr">17</xref>] and a patient-centered HIV care model with multi-disease integration (chronic HIV, hypertension, and/or diabetes care) for both intervention and control participants [<xref rid="pone.0277312.ref005" ref-type="bibr">5</xref>]. Care was provided in collaboration between study clinicians and Ministry of Health clinicians at each government clinic. Medications were procured by the clinics and were supplemented by the study when clinic-procured medications were not available. All medications were provided to participants free of charge.</p>
              </sec>
              <sec id="sec009">
                <title>Measurements</title>
                <p>We conducted baseline surveys (i.e., at time of community-based hypertension screening) to record participant demographics, medical co-morbidities, and perceived barriers and facilitators of hypertension care engagement. Barriers and facilitators were assessed with an open-ended question about factors that would make it easier/more difficult to go to the clinic for hypertension care. Responses were coded with a structured set of answer choices that could be used as prompts when participants were unsure. We recorded clinical data from all hypertension care visits, including date of visit, blood pressure measured, and medications prescribed.</p>
                <p>At three months post-enrollment, we conducted follow-up study visits for all participants, regardless of linkage to hypertension care. We collected data on self-reported linkage to any alternative clinical sites for hypertension care and any barriers/facilitators that participants experienced to accessing hypertension care using the same method described above. We measured blood pressure, conducting three measures in all participants using an automated BP machine and correctly sized cuff after the participant had been seated quietly with back and arm supported for five minutes, with repeat measurements made after 1–2 minute intervals. Hypertension was considered controlled if all three measures were &lt;140 mmHg systolic and &lt;90 mmHg diastolic.</p>
              </sec>
              <sec id="sec010">
                <title>Outcomes and analysis</title>
                <p>Our primary outcome was linkage to hypertension care at the local Ministry of Health clinic within 30 days of referral. In primary analyses, participants without a clinical record indicating linkage were assumed never to link, while sensitivity analyses incorporated self-report. Secondary outcomes included hypertension control &lt;140/90 mmHg measured regardless of linkage at 90 days, linkage to any hypertension care by 90 days (linkage to Ministry of Health clinic or self-report of linkage to alternative site), retention in hypertension care at 90 days (linked to hypertension care and not late for most recent appointment by ≥30 days). We additionally describe medication initiation by trial arm and fidelity to intervention components. For primary and secondary outcomes, we used targeted minimum loss-based estimation (TMLE) to compute adjusted risk ratios (aRR) and 95% confidence intervals (95% CI) (<xref rid="pone.0277312.s001" ref-type="supplementary-material">S1 File</xref>) [<xref rid="pone.0277312.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0277312.ref019" ref-type="bibr">19</xref>]. In brief, TMLE combines estimates of outcome risk with estimates of propensity score and incorporates adjustment for baseline covariates to improve precision [<xref rid="pone.0277312.ref020" ref-type="bibr">20</xref>–<xref rid="pone.0277312.ref022" ref-type="bibr">22</xref>]. We selected adjustment variables (candidates were age, sex, hypertension severity, and site) with cross-validation. We also compared by arm the average of the second and third blood pressure measurements. To explore heterogeneity of intervention effects, we also repeated analyses within subgroups defined by sex, age group, country, baseline hypertension severity, and HIV status.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec011">
              <title>Results</title>
              <p>We screened 1,998 participants, identifying 369 (18.5%) with uncontrolled hypertension. Among 229 eligible persons, we enrolled 199 (100 control, 99 intervention; <xref rid="pone.0277312.g001" ref-type="fig">Fig 1</xref>). Reasons for ineligibility included prior hypertension diagnosis (n = 108) and hypertensive emergency (n = 32). People with hypertensive emergency at screening were immediately transported to the clinic for treatment. Among those with hypertensive emergency, mean SBP was 198 mmHg (standard deviation [SD] 15) and mean DBP was 104 mmHg (SD 12); symptoms included visual disturbances (n = 18, 56%), headache (n = 16, 50%), chest pain (n = 11, 34%), shortness of breath (n = 9, 28%) and recent lapse in consciousness (n = 6, 19%).</p>
              <fig position="float" id="pone.0277312.g001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0277312.g001</object-id>
                <label>Fig 1</label>
                <caption>
                  <title>Consort diagram.</title>
                </caption>
                <graphic xlink:href="pone.0277312.g001" position="float"/>
              </fig>
              <p>Of the enrolled participants 60% were female, median age was 56 (range 27–99) years, and 87% had completed primary education or less (<xref rid="pone.0277312.t001" ref-type="table">Table 1</xref>). Mean baseline SBP was 161 mmHg (SD 14) and 42% had baseline blood pressure ≥160/100 mmHg. Median self-reported direct cost of transport to the clinic was $0.93 USD (range $0.19 to $4.67) and median transport time was 45 minutes (range 2 to 300 minutes). Self-reported co-morbid conditions included HIV (n = 19, 10%) and diabetes (n = 3, 2%). HIV screening was offered to all participants at baseline; 100 (50%) were tested, among whom one participant was newly diagnosed with HIV. Reasons for declining HIV testing included known HIV-positive status (n = 19), having a negative test in the past 6 months and thus not meeting country guidelines for retesting (n = 41), declining testing (n = 14), and never linking to the clinic to offer HIV testing (n = 26).</p>
              <table-wrap position="float" id="pone.0277312.t001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0277312.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>Baseline characteristics.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0277312.t001" id="pone.0277312.t001g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">Intervention (N = 100) n (%)</th>
                        <th align="center" rowspan="1" colspan="1">Control (N = 99) n (%)</th>
                        <th align="center" rowspan="1" colspan="1">Overall (N = 199) n (%)</th>
                        <th align="center" rowspan="1" colspan="1">p-value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Country</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">1.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Kenya</td>
                        <td align="center" rowspan="1" colspan="1">50 (50.0)</td>
                        <td align="center" rowspan="1" colspan="1">49 (49.5)</td>
                        <td align="center" rowspan="1" colspan="1">99 (49.7)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Uganda</td>
                        <td align="center" rowspan="1" colspan="1">50 (50.0)</td>
                        <td align="center" rowspan="1" colspan="1">50 (50.5)</td>
                        <td align="center" rowspan="1" colspan="1">100 (50.3)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Age (years)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.63</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 25–39</td>
                        <td align="center" rowspan="1" colspan="1">15 (15.0)</td>
                        <td align="center" rowspan="1" colspan="1">16 (16.2)</td>
                        <td align="center" rowspan="1" colspan="1">31 (15.6)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 40–54</td>
                        <td align="center" rowspan="1" colspan="1">28 (28.0)</td>
                        <td align="center" rowspan="1" colspan="1">31 (31.3)</td>
                        <td align="center" rowspan="1" colspan="1">59 (29.6)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 55–69</td>
                        <td align="center" rowspan="1" colspan="1">36 (36.0)</td>
                        <td align="center" rowspan="1" colspan="1">39 (39.4)</td>
                        <td align="center" rowspan="1" colspan="1">75 (37.7)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 70–84</td>
                        <td align="center" rowspan="1" colspan="1">18 (18.0)</td>
                        <td align="center" rowspan="1" colspan="1">12 (12.1)</td>
                        <td align="center" rowspan="1" colspan="1">30 (15.1)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> &gt;84</td>
                        <td align="center" rowspan="1" colspan="1">3 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1">1 (1.0)</td>
                        <td align="center" rowspan="1" colspan="1">4 (2.0)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Sex</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">1.00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Female</td>
                        <td align="center" rowspan="1" colspan="1">60 (60.0)</td>
                        <td align="center" rowspan="1" colspan="1">59 (59.6)</td>
                        <td align="center" rowspan="1" colspan="1">119 (59.8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Male</td>
                        <td align="center" rowspan="1" colspan="1">40 (40.0)</td>
                        <td align="center" rowspan="1" colspan="1">40 (40.4)</td>
                        <td align="center" rowspan="1" colspan="1">80 (40.2)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Marital status</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.67</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Monogamous marriage</td>
                        <td align="center" rowspan="1" colspan="1">58 (58.0)</td>
                        <td align="center" rowspan="1" colspan="1">56 (56.6)</td>
                        <td align="center" rowspan="1" colspan="1">114 (57.3)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Polygamous marriage</td>
                        <td align="center" rowspan="1" colspan="1">17 (17.0)</td>
                        <td align="center" rowspan="1" colspan="1">21 (21.2)</td>
                        <td align="center" rowspan="1" colspan="1">39 (19.6)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Widowed, divorced, or separated</td>
                        <td align="center" rowspan="1" colspan="1">22 (22.0)</td>
                        <td align="center" rowspan="1" colspan="1">17 (17.0)</td>
                        <td align="center" rowspan="1" colspan="1">38 (19.1)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Unmarried or cohabitating</td>
                        <td align="center" rowspan="1" colspan="1">3 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1">6 (6.0)</td>
                        <td align="center" rowspan="1" colspan="1">8 (4.0)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Occupation</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.62</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Farmer</td>
                        <td align="center" rowspan="1" colspan="1">71 (71.0)</td>
                        <td align="center" rowspan="1" colspan="1">64 (64.6)</td>
                        <td align="center" rowspan="1" colspan="1">135 (67.8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> No job</td>
                        <td align="center" rowspan="1" colspan="1">8 (8.0)</td>
                        <td align="center" rowspan="1" colspan="1">7 (7.1)</td>
                        <td align="center" rowspan="1" colspan="1">15 (7.5)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Teacher</td>
                        <td align="center" rowspan="1" colspan="1">3 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1">5 (5.1)</td>
                        <td align="center" rowspan="1" colspan="1">8 (4.0)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Other</td>
                        <td align="center" rowspan="1" colspan="1">18 (18.0)</td>
                        <td align="center" rowspan="1" colspan="1">23 (23.2)</td>
                        <td align="center" rowspan="1" colspan="1">32 (16.1)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Monthly Income (USD)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
                        <td align="center" rowspan="1" colspan="1">21 (34)</td>
                        <td align="center" rowspan="1" colspan="1">27 (29)</td>
                        <td align="center" rowspan="1" colspan="1">24 (32)</td>
                        <td align="center" rowspan="1" colspan="1">0.27</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Median (Q1-Q3)</td>
                        <td align="center" rowspan="1" colspan="1">11 (5.7–23)</td>
                        <td align="center" rowspan="1" colspan="1">17 (6.6–37)</td>
                        <td align="center" rowspan="1" colspan="1">11 (5.7–34)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Missing</td>
                        <td align="center" rowspan="1" colspan="1">16 (16.0)</td>
                        <td align="center" rowspan="1" colspan="1">16 (16.2)</td>
                        <td align="center" rowspan="1" colspan="1">32 (16.1)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Transport cost to clinic (USD)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
                        <td align="center" rowspan="1" colspan="1">1.27 (0.70)</td>
                        <td align="center" rowspan="1" colspan="1">1.12 (0.54)</td>
                        <td align="center" rowspan="1" colspan="1">1.19 (0.63)</td>
                        <td align="center" rowspan="1" colspan="1">0.10</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Median (Q1-Q3)</td>
                        <td align="center" rowspan="1" colspan="1">1.1 (0.86–1.4)</td>
                        <td align="center" rowspan="1" colspan="1">0.93 (0.86–1.4)</td>
                        <td align="center" rowspan="1" colspan="1">0.93 (0.86–1.4)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Mobile phone access</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.69</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> No</td>
                        <td align="center" rowspan="1" colspan="1">14 (14.0)</td>
                        <td align="center" rowspan="1" colspan="1">16 (16.2)</td>
                        <td align="center" rowspan="1" colspan="1">30 (15.1)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Yes</td>
                        <td align="center" rowspan="1" colspan="1">86 (86.0)</td>
                        <td align="center" rowspan="1" colspan="1">83 (83.8)</td>
                        <td align="center" rowspan="1" colspan="1">169 (84.9)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Education</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.78</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Less than primary</td>
                        <td align="center" rowspan="1" colspan="1">55 (55.0)</td>
                        <td align="center" rowspan="1" colspan="1">62 (62.6)</td>
                        <td align="center" rowspan="1" colspan="1">117 (58.8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Completed primary</td>
                        <td align="center" rowspan="1" colspan="1">32 (32.0)</td>
                        <td align="center" rowspan="1" colspan="1">25 (25.3)</td>
                        <td align="center" rowspan="1" colspan="1">57 (28.6)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Completed secondary</td>
                        <td align="center" rowspan="1" colspan="1">3 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1">3 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1">6 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Completed post-secondary</td>
                        <td align="center" rowspan="1" colspan="1">10 (10.0)</td>
                        <td align="center" rowspan="1" colspan="1">9 (9.1)</td>
                        <td align="center" rowspan="1" colspan="1">19 (9.5)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Baseline diabetes</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">2 (2.0)</td>
                        <td align="center" rowspan="1" colspan="1">1 (1.0)</td>
                        <td align="center" rowspan="1" colspan="1">3 (1.5)</td>
                        <td align="center" rowspan="1" colspan="1">0.56</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Baseline HIV<xref rid="t001fn001" ref-type="table-fn">*</xref></bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">6 (6.0)</td>
                        <td align="center" rowspan="1" colspan="1">14 (14.1)</td>
                        <td align="center" rowspan="1" colspan="1">20 (10.0)</td>
                        <td align="center" rowspan="1" colspan="1">0.06</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Baseline Hypertension Stage (mmHg)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.93</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 140-159/90-99</td>
                        <td align="center" rowspan="1" colspan="1">58 (58.0)</td>
                        <td align="center" rowspan="1" colspan="1">58 (58.6)</td>
                        <td align="center" rowspan="1" colspan="1">116 (58.3)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> 160-179/100-109</td>
                        <td align="center" rowspan="1" colspan="1">38 (38.0)</td>
                        <td align="center" rowspan="1" colspan="1">38 (38.4)</td>
                        <td align="center" rowspan="1" colspan="1">76 (38.2)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> ≥180/110</td>
                        <td align="center" rowspan="1" colspan="1">4 (4.0)</td>
                        <td align="center" rowspan="1" colspan="1">3 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1">7 (3.5)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>SBP at baseline (mmHg)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Mean (SD)</td>
                        <td align="center" rowspan="1" colspan="1">160 (13.1)</td>
                        <td align="center" rowspan="1" colspan="1">161 (14.8)</td>
                        <td align="center" rowspan="1" colspan="1">161 (13.9)</td>
                        <td align="center" rowspan="1" colspan="1">0.77</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Median (Q1-Q3)</td>
                        <td align="center" rowspan="1" colspan="1">157 (149–169)</td>
                        <td align="center" rowspan="1" colspan="1">158 (147–171)</td>
                        <td align="center" rowspan="1" colspan="1">158 (149–170)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t001fn001">
                    <p>* Including self-report and one new diagnosis on baseline screening.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="sec012">
                <title>Primary and secondary outcomes</title>
                <p>Linkage to care within 30 days was 96/100 (96%) in intervention and 65/99 (66%) in control, a relative improvement of 45% (aRR 1.45, 95% CI 1.25–1.68; <xref rid="pone.0277312.t002" ref-type="table">Table 2</xref>) and an absolute improvement of 30% (risk difference 0.30, 95% CI 0.20–0.40). The intervention improved linkage to care within 30 days across strata of age, gender, country, baseline hypertension severity, and HIV status (<xref rid="pone.0277312.t003" ref-type="table">Table 3</xref>). The largest effect was seen among those with baseline blood pressure ≥160/100 mmHg, among whom the intervention increased linkage by 69% (aRR 1.69, 95% CI 1.31–2.18). After expanding the period to 90 days and incorporating self-reported any health facility, linkage remained at 96% in the intervention and increased to 77% in the control group (n = 74 at local Ministry of Health clinic and n = 2 to other self-reported clinic) (aRR 1.24, 95% CI 1.11–1.40).</p>
                <table-wrap position="float" id="pone.0277312.t002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0277312.t002</object-id>
                  <label>Table 2</label>
                  <caption>
                    <title>Main study outcomes.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0277312.t002" id="pone.0277312.t002g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Intervention (N = 100) n (%)</th>
                          <th align="center" rowspan="1" colspan="1">Control (N = 99) n (%)</th>
                          <th align="center" rowspan="1" colspan="1">aRR (95% CI)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Linked to care by 30 days</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">96 (96)</td>
                          <td align="center" rowspan="1" colspan="1">65 (66)</td>
                          <td align="center" rowspan="1" colspan="1">1.45 (1.25, 1.68)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Linked to care by 3 months <xref rid="t002fn001" ref-type="table-fn">*</xref></bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">96 (96)</td>
                          <td align="center" rowspan="1" colspan="1">77 (78)</td>
                          <td align="center" rowspan="1" colspan="1">1.24 (1.11, 1.39)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Retained in care at 3 months <xref rid="t002fn002" ref-type="table-fn">†</xref></bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">78 (78)</td>
                          <td align="center" rowspan="1" colspan="1">67 (68)</td>
                          <td align="center" rowspan="1" colspan="1">1.15 (0.97, 1.37)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Started on ≥1 hypertension medication <xref rid="t002fn003" ref-type="table-fn">‡</xref></bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Any</td>
                          <td align="center" rowspan="1" colspan="1">48 (48)</td>
                          <td align="center" rowspan="1" colspan="1">40 (40)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 1</td>
                          <td align="center" rowspan="1" colspan="1">20 (20)</td>
                          <td align="center" rowspan="1" colspan="1">18 (18)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 2</td>
                          <td align="center" rowspan="1" colspan="1">26 (26)</td>
                          <td align="center" rowspan="1" colspan="1">21 (21)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 3</td>
                          <td align="center" rowspan="1" colspan="1">2 (2)</td>
                          <td align="center" rowspan="1" colspan="1">1 (1)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Hypertension control at 3 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">51 (51)</td>
                          <td align="center" rowspan="1" colspan="1">41 (41)</td>
                          <td align="center" rowspan="1" colspan="1">1.23 (0.92, 1.66)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Mean SBP at 3 months</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1">140</td>
                          <td align="center" rowspan="1" colspan="1">141</td>
                          <td align="center" rowspan="1" colspan="1">0.99 (0.96, 1.02)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t002fn001">
                      <p>* including self-reported linkage to alternative clinic.</p>
                    </fn>
                    <fn id="t002fn002">
                      <p>† not late for most recent hypertension clinic visit by ≥30 days (assessed at 3 months post-enrollment).</p>
                    </fn>
                    <fn id="t002fn003">
                      <p>‡ Outcome not prespecified and no between arm comparison undertaken.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap position="float" id="pone.0277312.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0277312.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Linkage to care within 30 days, stratified by baseline participant characteristics.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0277312.t003" id="pone.0277312.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Intervention (N = 100)</th>
                          <th align="center" rowspan="1" colspan="1">Control (N = 99)</th>
                          <th align="center" rowspan="1" colspan="1">aRR (95% CI)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Gender</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Men</td>
                          <td align="center" rowspan="1" colspan="1">0.95</td>
                          <td align="center" rowspan="1" colspan="1">0.67</td>
                          <td align="center" rowspan="1" colspan="1">1.41 (1.12, 1.77)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Women</td>
                          <td align="center" rowspan="1" colspan="1">0.97</td>
                          <td align="center" rowspan="1" colspan="1">0.65</td>
                          <td align="center" rowspan="1" colspan="1">1.49 (1.24, 1.81)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> &lt; 60 years</td>
                          <td align="center" rowspan="1" colspan="1">0.97</td>
                          <td align="center" rowspan="1" colspan="1">0.62</td>
                          <td align="center" rowspan="1" colspan="1">1.56 (1.27, 1.92)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> ≥60 years</td>
                          <td align="center" rowspan="1" colspan="1">0.95</td>
                          <td align="center" rowspan="1" colspan="1">0.72</td>
                          <td align="center" rowspan="1" colspan="1">1.32 (1.08, 1.60)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Country</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Uganda</td>
                          <td align="center" rowspan="1" colspan="1">0.94</td>
                          <td align="center" rowspan="1" colspan="1">0.59</td>
                          <td align="center" rowspan="1" colspan="1">1.58 (1.25, 2.00)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Kenya</td>
                          <td align="center" rowspan="1" colspan="1">0.98</td>
                          <td align="center" rowspan="1" colspan="1">0.72</td>
                          <td align="center" rowspan="1" colspan="1">1.36 (1.14, 1.63)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline Hypertension Stage</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 140-159/90-99 mmHg</td>
                          <td align="center" rowspan="1" colspan="1">0.93</td>
                          <td align="center" rowspan="1" colspan="1">0.71</td>
                          <td align="center" rowspan="1" colspan="1">1.32 (1.1, 1.58)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> ≥160/100 mmHg</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">0.59</td>
                          <td align="center" rowspan="1" colspan="1">1.69 (1.31, 2.18)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline HIV status</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV-positive</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">0.8</td>
                          <td align="center" rowspan="1" colspan="1">1.26 (0.96, 1.65)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV-negative</td>
                          <td align="center" rowspan="1" colspan="1">0.96</td>
                          <td align="center" rowspan="1" colspan="1">0.64</td>
                          <td align="center" rowspan="1" colspan="1">1.49 (1.27, 1.76)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <p>Hypertension control &lt;140/90 mmHg at three months was measured independently from clinical care in 96/100 (96%) of intervention participants and 99/99 (100%) in control); participants with missing measures were assumed uncontrolled. Hypertension control was 51/100 (51%) in intervention and 41/99 (41%) in control (aRR 1.23, 95% CI 0.92–1.66). Among persons with baseline blood pressure ≥160/100 mmHg, hypertension control was 46% in intervention and 26% in control (aRR 1.78, 95% CI 0.98–3.22; <xref rid="pone.0277312.t004" ref-type="table">Table 4</xref>). Mean SBP at three months was 140 mmHg in intervention and 141 mmHg in control.</p>
                <table-wrap position="float" id="pone.0277312.t004">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0277312.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Hypertension control at 3 months, stratified by baseline participant characteristics.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0277312.t004" id="pone.0277312.t004g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Intervention (N = 100)</th>
                          <th align="center" rowspan="1" colspan="1">Control (N = 99)</th>
                          <th align="center" rowspan="1" colspan="1">aRR (95% CI)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Gender</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Men</td>
                          <td align="center" rowspan="1" colspan="1">0.46</td>
                          <td align="center" rowspan="1" colspan="1">0.41</td>
                          <td align="center" rowspan="1" colspan="1">1.13 (0.69, 1.84)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Women</td>
                          <td align="center" rowspan="1" colspan="1">0.55</td>
                          <td align="center" rowspan="1" colspan="1">0.42</td>
                          <td align="center" rowspan="1" colspan="1">1.32 (0.91, 1.93)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> &lt; 60 years</td>
                          <td align="center" rowspan="1" colspan="1">0.51</td>
                          <td align="center" rowspan="1" colspan="1">0.41</td>
                          <td align="center" rowspan="1" colspan="1">1.23 (0.84, 1.82)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> ≥60 years</td>
                          <td align="center" rowspan="1" colspan="1">0.49</td>
                          <td align="center" rowspan="1" colspan="1">0.44</td>
                          <td align="center" rowspan="1" colspan="1">1.09 (0.71, 1.69)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Country</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Uganda</td>
                          <td align="center" rowspan="1" colspan="1">0.42</td>
                          <td align="center" rowspan="1" colspan="1">0.3</td>
                          <td align="center" rowspan="1" colspan="1">1.4 (0.82, 2.38)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Kenya</td>
                          <td align="center" rowspan="1" colspan="1">0.6</td>
                          <td align="center" rowspan="1" colspan="1">0.54</td>
                          <td align="center" rowspan="1" colspan="1">1.12 (0.80, 1.58)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline Hypertension Stage</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 140-159/90-99 mmHg</td>
                          <td align="center" rowspan="1" colspan="1">0.52</td>
                          <td align="center" rowspan="1" colspan="1">0.55</td>
                          <td align="center" rowspan="1" colspan="1">0.95 (0.69, 1.30)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> ≥160/100 mmHg</td>
                          <td align="center" rowspan="1" colspan="1">0.46</td>
                          <td align="center" rowspan="1" colspan="1">0.26</td>
                          <td align="center" rowspan="1" colspan="1">1.78 (0.98, 3.22)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline HIV status</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV-positive</td>
                          <td align="center" rowspan="1" colspan="1">0.68</td>
                          <td align="center" rowspan="1" colspan="1">0.49</td>
                          <td align="center" rowspan="1" colspan="1">1.39 (0.64, 3.03)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV-negative</td>
                          <td align="center" rowspan="1" colspan="1">0.49</td>
                          <td align="center" rowspan="1" colspan="1">0.42</td>
                          <td align="center" rowspan="1" colspan="1">1.14 (0.85, 1.53)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec013">
                <title>Intervention fidelity and delivery of clinical hypertension care</title>
                <p>All intervention participants received transport reimbursement upon linkage. Of intervention participants who did not link to care by seven days and were eligible for a reminder call (n = 23), 13 (56%) were successfully reached by phone, one (4%) was reached via an informant, six (26%) linked to care before a phone call could be initiated, and three (13%) could not be reached by phone. Among those who did not link to care by their initial clinic appointment date (scheduled within seven days of enrollment), 83% (n = 19/23) of intervention participants and 26% (n = 12/46) of control participants ultimately linked to hypertension care by 30 days post-enrollment.</p>
                <p>Among those who linked to care (n = 175), 50 (29%) had normal blood pressure (&lt;140/90 mmHg) on their initial clinic visit, 88 (50%) had stage 1 hypertension (BP 140-159/90-99 mmHg), and 37 (21%) had stage 2 or greater hypertension (BP ≥160/100 mmHg). Among those with stage 1 hypertension, 58% received lifestyle counseling and 42% were immediately initiated on antihypertensive medications. Among those with stage 2 or greater hypertension, 84% were initiated on antihypertensive medications at the first clinic visit. After three months, 48% (n = 48) of intervention participants and 40% (n = 40) of control participants had started at least one antihypertensive medication. Seventy-eight (78%) intervention participants and 67 (68%) control participants were retained in care by three months (aRR 1.15, 95% CI 0.97–1.37). In sub-group analysis, the intervention increased retention in care in women (aRR 1.34, 95% CI 1.06–1.70), Uganda (aRR 1.55, 95% CI 1.19–2.0), among those with grade 2 or greater baseline hypertension stage (aRR 1.32, 95% CI 1.02–1.70), and those who were HIV negative at baseline (aRR 1.17, 95% CI 0.98–1.4) (<xref rid="pone.0277312.t005" ref-type="table">Table 5</xref>).</p>
                <table-wrap position="float" id="pone.0277312.t005">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0277312.t005</object-id>
                  <label>Table 5</label>
                  <caption>
                    <title>Retention in care at 3 months, stratified by baseline participant characteristics.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0277312.t005" id="pone.0277312.t005g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Intervention (N = 100)</th>
                          <th align="center" rowspan="1" colspan="1">Control (N = 99)</th>
                          <th align="center" rowspan="1" colspan="1">aRR (95% CI)</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Gender</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Men</td>
                          <td align="center" rowspan="1" colspan="1">0.73</td>
                          <td align="center" rowspan="1" colspan="1">0.77</td>
                          <td align="center" rowspan="1" colspan="1">0.96 (0.75, 1.22)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Women</td>
                          <td align="center" rowspan="1" colspan="1">0.82</td>
                          <td align="center" rowspan="1" colspan="1">0.61</td>
                          <td align="center" rowspan="1" colspan="1">1.34 (1.06, 1.70)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> &lt; 60 years</td>
                          <td align="center" rowspan="1" colspan="1">0.78</td>
                          <td align="center" rowspan="1" colspan="1">0.7</td>
                          <td align="center" rowspan="1" colspan="1">1.11 (0.89, 1.38)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> ≥60 years</td>
                          <td align="center" rowspan="1" colspan="1">0.79</td>
                          <td align="center" rowspan="1" colspan="1">0.64</td>
                          <td align="center" rowspan="1" colspan="1">1.22 (0.93, 1.61)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Country</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Uganda</td>
                          <td align="center" rowspan="1" colspan="1">0.86</td>
                          <td align="center" rowspan="1" colspan="1">0.56</td>
                          <td align="center" rowspan="1" colspan="1">1.55 (1.19, 2.03)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> Kenya</td>
                          <td align="center" rowspan="1" colspan="1">0.7</td>
                          <td align="center" rowspan="1" colspan="1">0.8</td>
                          <td align="center" rowspan="1" colspan="1">0.88 (0.7, 1.11)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline Hypertension Stage</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> 140-159/90-99 mmHg</td>
                          <td align="center" rowspan="1" colspan="1">0.74</td>
                          <td align="center" rowspan="1" colspan="1">0.72</td>
                          <td align="center" rowspan="1" colspan="1">1.02 (0.82, 1.28)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> ≥160/100 mmHg</td>
                          <td align="center" rowspan="1" colspan="1">0.84</td>
                          <td align="center" rowspan="1" colspan="1">0.64</td>
                          <td align="center" rowspan="1" colspan="1">1.32 (1.02, 1.70)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Baseline HIV status</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV-positive</td>
                          <td align="center" rowspan="1" colspan="1">0.81</td>
                          <td align="center" rowspan="1" colspan="1">0.8</td>
                          <td align="center" rowspan="1" colspan="1">1.02 (0.67, 1.57)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"> HIV-negative</td>
                          <td align="center" rowspan="1" colspan="1">0.78</td>
                          <td align="center" rowspan="1" colspan="1">0.67</td>
                          <td align="center" rowspan="1" colspan="1">1.17 (0.98, 1.40)</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec014">
                <title>Self-reported barriers and facilitators of hypertension care engagement</title>
                <p>At baseline, 92% of participants cited health concerns as reasons why they were likely to seek hypertension care (61% cited worry about their hypertension diagnosis and 43% cited feeling sick and wanting to seek care). Over half (57%) cited transportation difficulties as reasons why they were less likely to seek hypertension care (50% cited transportation expense and 11% cited long distance or difficulties with physical mobility) (<xref rid="pone.0277312.g002" ref-type="fig">Fig 2</xref>).</p>
                <fig position="float" id="pone.0277312.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0277312.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Self-reported barriers and facilitators of engagement in hypertension care.</title>
                  </caption>
                  <graphic xlink:href="pone.0277312.g002" position="float"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec015">
              <title>Discussion</title>
              <p>Following community-based hypertension screening, a one-time financial incentive and reminder call for missed visits resulted in a 30% absolute increase in linkage to hypertension care within 30 days, compared to standard referrals. Increased linkage to care translated to a greater proportion of participants achieving hypertension control &lt;140/90 mmHg in the intervention arm, though overall hypertension control remained sub-optimal.</p>
              <p>Across sub-Saharan Africa, an estimated 27% of adults with hypertension are aware of their diagnosis, with only 18% currently on treatment, and 7% with controlled hypertension [<xref rid="pone.0277312.ref002" ref-type="bibr">2</xref>]. Limitations in diagnosis and treatment are similar in East Africa [<xref rid="pone.0277312.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0277312.ref003" ref-type="bibr">3</xref>, <xref rid="pone.0277312.ref023" ref-type="bibr">23</xref>], even among those at greatest CVD risk [<xref rid="pone.0277312.ref024" ref-type="bibr">24</xref>]. We previously showed that patient-centered hypertension care can improve hypertension control and reduce all-cause mortality among adults with uncontrolled hypertension identified through population-level screening; however, fewer than half of patients diagnosed with hypertension linked to care within one year, limiting the full benefits of treatment [<xref rid="pone.0277312.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0277312.ref025" ref-type="bibr">25</xref>]. Other studies have identified similar challenges linking patients to hypertension care following community-based screening. In the LARK cluster randomized controlled trial in Kenya, linkage to care within a year was 49% following community-based screening and referral to hypertension by community health workers (CHWs), with no added improvement in linkage achieved by training CHWs in behavioral communication and providing smartphones to facilitate health communication [<xref rid="pone.0277312.ref006" ref-type="bibr">6</xref>]. A mobile multi-disease screening intervention in South Africa also showed similar rates of linkage to hypertension care of approximately 50% [<xref rid="pone.0277312.ref007" ref-type="bibr">7</xref>].</p>
              <p>Incentives may improve linkage to care by reducing economic barriers, addressing present bias, and increasing extrinsic motivation [<xref rid="pone.0277312.ref026" ref-type="bibr">26</xref>]. In our study, self-reported round trip transportation costs for a single clinic visit were approximately 8% of median monthly wages, and transportation time/cost was the most commonly reported reason for not seeking hypertension care. The size of our one-time incentive was approximately 5-fold greater than median transportation costs with the goal of directly reimbursing transportation costs, addressing opportunity costs associated with clinic attendance, and providing extrinsic motivation. A recent RCT in Kenya showed small, non-significant reductions in systolic blood pressure when coupling hypertension care with a microfinance intervention designed to improve financial stability, suggesting that interventions to address poverty may address some of the financial barriers to care engagement [<xref rid="pone.0277312.ref027" ref-type="bibr">27</xref>]. However, adding a conditional incentive to link to care may increase linkage more than a similarly valued non-conditional incentive, highlighting the important role of extrinsic motivation in linkage interventions, particularly for medical conditions, such as hypertension, where early-stage disease may be asymptomatic [<xref rid="pone.0277312.ref028" ref-type="bibr">28</xref>].</p>
              <p>Our incentives were not targeted towards any particular group, though evidence from the HIV literature also demonstrates that incentives may be particularly useful for promoting uptake of health services among groups who are less likely to seek healthcare services, particularly men [<xref rid="pone.0277312.ref029" ref-type="bibr">29</xref>–<xref rid="pone.0277312.ref031" ref-type="bibr">31</xref>]. Our one-time incentive had similar effects on linkage among men and women. However, once the incentive was no longer available (i.e. for follow-up visits), there was no sustained intervention effect on blood pressure control or retention in care among men. Future iterations of our intervention may consider a more targeted approach towards individuals who are less likely to engage with hypertension care on their own or who may be at higher risk of adverse outcomes if they do not link promptly.</p>
              <p>Our intervention was designed to overcome initial barriers to linkage to care but did not address ongoing transportation challenges that patients may face. Nonetheless, higher linkage to care in the intervention arm translated to higher short-term retention in care, suggesting that “getting patients in the door” may overcome the initial activation energy required to ensure consistent engagement in care, at least in the short term. Upon linkage, patients in both treatment arms received integrated, patient-centered hypertension care [<xref rid="pone.0277312.ref005" ref-type="bibr">5</xref>] and free antihypertensive medications, which likely attenuated differences in retention and hypertension control between arms. After three months, one-third of participants cited clinic factors as reasons for remaining in hypertension care (i.e. high quality of care, short waiting time, kind staff, and availability of medications), highlighting the value of high-quality care in encouraging retention.</p>
              <p>Our pilot study had several important limitations. First, follow-up time was short and may not have been enough time to see the full effect of antihypertensive medication up-titration or to understand whether intervention effects are sustained over time. Further, 30% of participants did not have sustained elevation of blood pressure on linkage. Guidelines recommend that a diagnosis of hypertension be made after demonstrating persistent blood pressure elevation over time [<xref rid="pone.0277312.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0277312.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0277312.ref033" ref-type="bibr">33</xref>], therefore many of these individuals may have been overdiagnosed on initial screening. Future cost-effectiveness analysis will help quantify the resource allocation trade-offs involved in providing incentives for linkage to care for all individuals with elevated blood pressure on screening, versus limiting enhanced interventions to those with greater elevations in blood pressure. Future study evaluating smaller incentives may also be needed to address issues of scalability. As an individual-level randomized trial, there is also the possibility of contamination between trial arms if participants shared their transportation vouchers, though this would have biased study findings towards the null. Finally, our study was not designed to address linkage for individuals with hypertensive emergency. During our community-based screening, one out of every 43 individuals screened had hypertensive urgency (blood pressure ≥180/110 mmHg) or emergency (urgency + new/severe associated symptoms). Given the high morbidity and mortality of this condition in sub-Saharan Africa [<xref rid="pone.0277312.ref034" ref-type="bibr">34</xref>–<xref rid="pone.0277312.ref041" ref-type="bibr">41</xref>] new intervention approaches are needed to address the urgent and more intensive treatment needs of this population.</p>
            </sec>
            <sec sec-type="conclusions" id="sec016">
              <title>Conclusions</title>
              <p>One-time financial incentives and phone-based follow-up to ensure linkage are effective strategies for increasing linkage to hypertension care following community-based screening in rural East Africa. Diagnosis and linkage to care are critical first steps to reducing disparities in hypertension treatment outcomes in sub-Saharan Africa; health system strengthening to deliver chronic hypertension care is essential to ensuring sustained treatment benefit.</p>
            </sec>
            <sec id="sec017" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0277312.s001" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <title>Statistical analysis plan.</title>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0277312.s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0277312.s002" position="float" content-type="local-data">
                <label>S2 File</label>
                <caption>
                  <title>Consort checklist.</title>
                  <p>(DOC)</p>
                </caption>
                <media xlink:href="pone.0277312.s002.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0277312.s003" position="float" content-type="local-data">
                <label>S3 File</label>
                <caption>
                  <title>Study protocol.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0277312.s003.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0277312.s004" position="float" content-type="local-data">
                <label>S4 File</label>
                <caption>
                  <title>Inclusivity in global research.</title>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0277312.s004.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0277312.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Geldsetzer</surname><given-names>P</given-names></name>, <name><surname>Manne-Goehler</surname><given-names>J</given-names></name>, <name><surname>Marcus</surname><given-names>ME</given-names></name>, <name><surname>Ebert</surname><given-names>C</given-names></name>, <name><surname>Zhumadilov</surname><given-names>Z</given-names></name>, <name><surname>Wesseh</surname><given-names>CS</given-names></name>, <etal>et al</etal>. <article-title>The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults</article-title>. <source>Lancet</source>. <year>2019</year> 24;<volume>394</volume>(<issue>10199</issue>):<fpage>652</fpage>–<lpage>62</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(19)30955-9</pub-id>
<?supplied-pmid 31327566?><pub-id pub-id-type="pmid">31327566</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Ataklte</surname><given-names>F</given-names></name>, <name><surname>Erqou</surname><given-names>S</given-names></name>, <name><surname>Kaptoge</surname><given-names>S</given-names></name>, <name><surname>Taye</surname><given-names>B</given-names></name>, <name><surname>Echouffo-Tcheugui</surname><given-names>JB</given-names></name>, <name><surname>Kengne</surname><given-names>AP</given-names></name>. <article-title>Burden of undiagnosed hypertension in sub-Saharan Africa: a systematic review and meta-analysis</article-title>. <source>Hypertension</source>. <year>2015</year><month>Feb</month>;<volume>65</volume>(<issue>2</issue>):<fpage>291</fpage>–<lpage>8</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.114.04394</pub-id>
<?supplied-pmid 25385758?><pub-id pub-id-type="pmid">25385758</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Wamai</surname><given-names>RG</given-names></name>, <name><surname>Kengne</surname><given-names>AP</given-names></name>, <name><surname>Levitt</surname><given-names>N</given-names></name>. <article-title>Non-communicable diseases surveillance: overview of magnitude and determinants in Kenya from STEPwise approach survey of 2015</article-title>. <source>BMC Public Health</source>. <year>2018</year><month>Nov</month><day>7</day>;<volume>18</volume>(<issue>3</issue>):<fpage>1224</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12889-018-6051-z</pub-id><?supplied-pmid 30400841?><pub-id pub-id-type="pmid">30400841</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><collab>NCD Risk Factor Collaboration (NCD-RisC)</collab>. <article-title>Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants</article-title>. <source>Lancet</source>. <year>2021</year><month>Sep</month><day>11</day>;<volume>398</volume>(<issue>10304</issue>):<fpage>957</fpage>–<lpage>80</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/S0140-6736(21)01330-1</pub-id>
<?supplied-pmid 34450083?><pub-id pub-id-type="pmid">34450083</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Hickey</surname><given-names>MD</given-names></name>, <name><surname>Ayieko</surname><given-names>J</given-names></name>, <name><surname>Owaraganise</surname><given-names>A</given-names></name>, <name><surname>Sim</surname><given-names>N</given-names></name>, <name><surname>Balzer</surname><given-names>LB</given-names></name>, <name><surname>Kabami</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda</article-title>. <source>PLoS Med</source>. <year>2021</year><month>Sep</month><day>20</day>;<volume>18</volume>(<issue>9</issue>):<fpage>e1003803</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1003803</pub-id><?supplied-pmid 34543267?><pub-id pub-id-type="pmid">34543267</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Vedanthan</surname><given-names>R</given-names></name>, <name><surname>Kamano</surname><given-names>JH</given-names></name>, <name><surname>DeLong</surname><given-names>AK</given-names></name>, <name><surname>Naanyu</surname><given-names>V</given-names></name>, <name><surname>Binanay</surname><given-names>CA</given-names></name>, <name><surname>Bloomfield</surname><given-names>GS</given-names></name>, <etal>et al</etal>. <article-title>Community Health Workers Improve Linkage to Hypertension Care in Western Kenya</article-title>. <source>J Am Coll Cardiol</source>. <year>2019</year><month>Oct</month><day>15</day>;<volume>74</volume>(<issue>15</issue>):<fpage>1897</fpage>–<lpage>906</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jacc.2019.08.003</pub-id>
<?supplied-pmid 31487546?><pub-id pub-id-type="pmid">31487546</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Govindasamy</surname><given-names>D</given-names></name>, <name><surname>Kranzer</surname><given-names>K</given-names></name>, <name><surname>Schaik</surname><given-names>N van</given-names></name>, <name><surname>Noubary</surname><given-names>F</given-names></name>, <name><surname>Wood</surname><given-names>R</given-names></name>, <name><surname>Walensky</surname><given-names>RP</given-names></name>, <etal>et al</etal>. <article-title>Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa</article-title>. <source>PLOS ONE</source>. <year>2013</year><month>Nov</month><day>13</day>;<volume>8</volume>(<issue>11</issue>):<fpage>e80017</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0080017</pub-id><?supplied-pmid 24236170?><pub-id pub-id-type="pmid">24236170</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Brathwaite</surname><given-names>R</given-names></name>, <name><surname>Hutchinson</surname><given-names>E</given-names></name>, <name><surname>McKee</surname><given-names>M</given-names></name>, <name><surname>Palafox</surname><given-names>B</given-names></name>, <name><surname>Balabanova</surname><given-names>D</given-names></name>. <article-title>The Long and Winding Road: A Systematic Literature Review Conceptualising Pathways for Hypertension Care and Control in Low- and Middle-Income Countries</article-title>. <source>Int J Health Policy Manag</source>. <year>2020</year><month>Jul</month><day>18</day>.</mixed-citation>
              </ref>
              <ref id="pone.0277312.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Kwarisiima</surname><given-names>D</given-names></name>, <name><surname>Atukunda</surname><given-names>M</given-names></name>, <name><surname>Owaraganise</surname><given-names>A</given-names></name>, <name><surname>Chamie</surname><given-names>G</given-names></name>, <name><surname>Clark</surname><given-names>T</given-names></name>, <name><surname>Kabami</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study</article-title>. <source>BMC Public Health</source>. <year>2019</year><month>May</month><day>6</day>;<volume>19</volume>(<issue>1</issue>):<fpage>511</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12889-019-6838-6</pub-id><?supplied-pmid 31060545?><pub-id pub-id-type="pmid">31060545</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Wierzejska</surname><given-names>E</given-names></name>, <name><surname>Giernaś</surname><given-names>B</given-names></name>, <name><surname>Lipiak</surname><given-names>A</given-names></name>, <name><surname>Karasiewicz</surname><given-names>M</given-names></name>, <name><surname>Cofta</surname><given-names>M</given-names></name>, <name><surname>Staszewski</surname><given-names>R</given-names></name>. <article-title>A global perspective on the costs of hypertension: a systematic review</article-title>. <source>Arch Med Sci</source>. <year>2020</year>;<volume>16</volume>(<issue>5</issue>):<fpage>1078</fpage>–<lpage>91</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5114/aoms.2020.92689</pub-id>
<?supplied-pmid 32863997?><pub-id pub-id-type="pmid">32863997</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Muddu</surname><given-names>M</given-names></name>, <name><surname>Ssinabulya</surname><given-names>I</given-names></name>, <name><surname>Kigozi</surname><given-names>SP</given-names></name>, <name><surname>Ssennyonjo</surname><given-names>R</given-names></name>, <name><surname>Ayebare</surname><given-names>F</given-names></name>, <name><surname>Katwesigye</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Hypertension care cascade at a large urban HIV clinic in Uganda: a mixed methods study using the Capability, Opportunity, Motivation for Behavior change (COM-B) model</article-title>. <source>Implement Sci Commun</source>. <year>2021</year><month>Oct</month><day>20</day>;<volume>2</volume>(<issue>1</issue>):<fpage>121</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s43058-021-00223-9</pub-id><?supplied-pmid 34670624?><pub-id pub-id-type="pmid">34670624</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Kotwani</surname><given-names>P</given-names></name>, <name><surname>Balzer</surname><given-names>L</given-names></name>, <name><surname>Kwarisiima</surname><given-names>D</given-names></name>, <name><surname>Clark</surname><given-names>TD</given-names></name>, <name><surname>Kabami</surname><given-names>J</given-names></name>, <name><surname>Byonanebye</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Evaluating linkage to care for hypertension after community-based screening in rural Uganda</article-title>. <source>Tropical medicine &amp; international health: TM &amp; IH</source>. <year>2014</year><month>Apr</month>;<volume>19</volume>(<issue>4</issue>):<fpage>459</fpage>–<lpage>68</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/tmi.12273</pub-id>
<?supplied-pmid 24495307?><pub-id pub-id-type="pmid">24495307</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Koduah Owusu</surname><given-names>K</given-names></name>, <name><surname>Adu-Gyamfi</surname><given-names>R</given-names></name>, <name><surname>Ahmed</surname><given-names>Z</given-names></name>. <article-title>Strategies To Improve Linkage To HIV Care In Urban Areas Of Sub-Saharan Africa: A Systematic Review</article-title>. <source>HIV AIDS (Auckl)</source>. <year>2019</year>;<volume>11</volume>:<fpage>321</fpage>–<lpage>32</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2147/HIV.S216093</pub-id>
<?supplied-pmid 31819663?><pub-id pub-id-type="pmid">31819663</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>McNairy</surname><given-names>ML</given-names></name>, <name><surname>Lamb</surname><given-names>MR</given-names></name>, <name><surname>Gachuhi</surname><given-names>AB</given-names></name>, <name><surname>Nuwagaba-Biribonwoha</surname><given-names>H</given-names></name>, <name><surname>Burke</surname><given-names>S</given-names></name>, <name><surname>Mazibuko</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial</article-title>. <source>PLoS Med</source>. <year>2017</year><month>Nov</month>;<volume>14</volume>(<issue>11</issue>):<fpage>e1002420</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1002420</pub-id><?supplied-pmid 29112963?><pub-id pub-id-type="pmid">29112963</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Ayieko</surname><given-names>J</given-names></name>, <name><surname>Petersen</surname><given-names>ML</given-names></name>, <name><surname>Charlebois</surname><given-names>ED</given-names></name>, <name><surname>Brown</surname><given-names>LB</given-names></name>, <name><surname>Clark</surname><given-names>TD</given-names></name>, <name><surname>Kwarisiima</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya</article-title>. <source>Journal of acquired immune deficiency syndromes (1999)</source>. <year>2019</year><month>Apr</month><day>1</day>;<volume>80</volume>(<issue>4</issue>):<fpage>414</fpage>–<lpage>22</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/QAI.0000000000001939</pub-id>
<?supplied-pmid 30807481?><pub-id pub-id-type="pmid">30807481</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref016">
                <label>16</label>
                <mixed-citation publication-type="other">Kenya National Guidelines for Cardiovascular Diseases Management [Internet]. Division of Non-Communicable Diseases, Ministry of Health, Kenya; 2018. Available from: <ext-link xlink:href="https://www.health.go.ke/wp-content/uploads/2018/06/Cardiovascular-guidelines-2018_A4_Final.pdf" ext-link-type="uri">https://www.health.go.ke/wp-content/uploads/2018/06/Cardiovascular-guidelines-2018_A4_Final.pdf</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref017">
                <label>17</label>
                <mixed-citation publication-type="other">Uganda Clinical Guidelines: National Guidelines for Management of Common Conditions. Republic of Uganda Ministry of Health; 2016.</mixed-citation>
              </ref>
              <ref id="pone.0277312.ref018">
                <label>18</label>
                <mixed-citation publication-type="book"><name><surname>Van Der Laan</surname><given-names>M</given-names></name>, <name><surname>Rose</surname><given-names>S</given-names></name>. <source>Targeted Learning: Causal Inference for Observational and Experimental Data</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2011</year>. <fpage>628</fpage> p. (Springer Series in Statistics).</mixed-citation>
              </ref>
              <ref id="pone.0277312.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Balzer</surname><given-names>LB</given-names></name>, <name><surname>van der Laan</surname><given-names>MJ</given-names></name>, <name><surname>Petersen</surname><given-names>ML</given-names></name>, <collab>SEARCH Collaboration</collab>. <article-title>Adaptive pre-specification in randomized trials with and without pair-matching</article-title>. <source>Stat Med</source>. <year>2016</year> 10;<volume>35</volume>(<issue>25</issue>):<fpage>4528</fpage>–<lpage>45</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.7023</pub-id>
<?supplied-pmid 27436797?><pub-id pub-id-type="pmid">27436797</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Moore</surname><given-names>KL</given-names></name>, <name><surname>van der Laan</surname><given-names>MJ</given-names></name>. <article-title>Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation</article-title>. <source>Stat Med</source>. <year>2009</year><month>Jan</month><day>15</day>;<volume>28</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>64</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.3445</pub-id>
<?supplied-pmid 18985634?><pub-id pub-id-type="pmid">18985634</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Rosenblum</surname><given-names>M</given-names></name>, <name><surname>van der Laan</surname><given-names>MJ</given-names></name>. <article-title>Simple, efficient estimators of treatment effects in randomized trials using generalized linear models to leverage baseline variables</article-title>. <source>Int J Biostat</source>. <year>2010</year><month>Apr</month><day>1</day>;<volume>6</volume>(<issue>1</issue>):Article 13. <comment>doi: </comment><pub-id pub-id-type="doi">10.2202/1557-4679.1138</pub-id><?supplied-pmid 20628636?><pub-id pub-id-type="pmid">20628636</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Benkeser</surname><given-names>D</given-names></name>, <name><surname>Díaz</surname><given-names>I</given-names></name>, <name><surname>Luedtke</surname><given-names>A</given-names></name>, <name><surname>Segal</surname><given-names>J</given-names></name>, <name><surname>Scharfstein</surname><given-names>D</given-names></name>, <name><surname>Rosenblum</surname><given-names>M</given-names></name>. <article-title>Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes</article-title>. <source>Biometrics</source>. <year>2021</year><month>Dec</month>;<volume>77</volume>(<issue>4</issue>):<fpage>1467</fpage>–<lpage>81</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/biom.13377</pub-id>
<?supplied-pmid 32978962?><pub-id pub-id-type="pmid">32978962</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Kwarisiima</surname><given-names>D</given-names></name>, <name><surname>Balzer</surname><given-names>L</given-names></name>, <name><surname>Heller</surname><given-names>D</given-names></name>, <name><surname>Kotwani</surname><given-names>P</given-names></name>, <name><surname>Chamie</surname><given-names>G</given-names></name>, <name><surname>Clark</surname><given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Population-Based Assessment of Hypertension Epidemiology and Risk Factors among</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>5</issue>):<fpage>e0156309</fpage>.<pub-id pub-id-type="pmid">27232186</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Peiris</surname><given-names>D</given-names></name>, <name><surname>Ghosh</surname><given-names>A</given-names></name>, <name><surname>Manne-Goehler</surname><given-names>J</given-names></name>, <name><surname>Jaacks</surname><given-names>LM</given-names></name>, <name><surname>Theilmann</surname><given-names>M</given-names></name>, <name><surname>Marcus</surname><given-names>ME</given-names></name>, <etal>et al</etal>. <article-title>Cardiovascular disease risk profile and management practices in 45 low-income and middle-income countries: A cross-sectional study of nationally representative individual-level survey data</article-title>. <source>PLoS Med</source>. <year>2021</year><month>Mar</month>;<volume>18</volume>(<issue>3</issue>):<fpage>e1003485</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1003485</pub-id><?supplied-pmid 33661979?><pub-id pub-id-type="pmid">33661979</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Havlir</surname><given-names>DV</given-names></name>, <name><surname>Balzer</surname><given-names>LB</given-names></name>, <name><surname>Charlebois</surname><given-names>ED</given-names></name>, <name><surname>Clark</surname><given-names>TD</given-names></name>, <name><surname>Kwarisiima</surname><given-names>D</given-names></name>, <name><surname>Ayieko</surname><given-names>J</given-names></name>, <etal>et al</etal>. <article-title>HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa</article-title>. <source>New England Journal of Medicine</source>. <year>2019</year><month>Jul</month><day>18</day>;<volume>381</volume>(<issue>3</issue>):<fpage>219</fpage>–<lpage>29</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1056/NEJMoa1809866</pub-id>
<?supplied-pmid 31314966?><pub-id pub-id-type="pmid">31314966</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>de Walque</surname><given-names>D.</given-names></name><article-title>The use of financial incentives to prevent unhealthy behaviors: A review</article-title>. <source>Social Science &amp; Medicine</source>. <year>2020</year><month>Sep</month><day>1</day>;<volume>261</volume>:<fpage>113236</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.socscimed.2020.113236</pub-id><?supplied-pmid 32781370?><pub-id pub-id-type="pmid">32781370</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Vedanthan</surname><given-names>R</given-names></name>, <name><surname>Kamano</surname><given-names>JH</given-names></name>, <name><surname>Chrysanthopoulou</surname><given-names>SA</given-names></name>, <name><surname>Mugo</surname><given-names>R</given-names></name>, <name><surname>Andama</surname><given-names>B</given-names></name>, <name><surname>Bloomfield</surname><given-names>GS</given-names></name>, <etal>et al</etal>. <article-title>Group Medical Visit and Microfinance Intervention for Patients With Diabetes or Hypertension in Kenya</article-title>. <source>J Am Coll Cardiol</source>. <year>2021</year><month>Apr</month><day>27</day>;<volume>77</volume>(<issue>16</issue>):<fpage>2007</fpage>–<lpage>18</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jacc.2021.03.002</pub-id>
<?supplied-pmid 33888251?><pub-id pub-id-type="pmid">33888251</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>de Walque</surname><given-names>D</given-names></name>, <name><surname>Chukwuma</surname><given-names>A</given-names></name>, <name><surname>Ayivi-Guedehoussou</surname><given-names>N</given-names></name>, <name><surname>Koshkakaryan</surname><given-names>M</given-names></name>. <article-title>Invitations, incentives, and conditions: A randomized evaluation of demand-side interventions for health screenings</article-title>. <source>Soc Sci Med</source>. <year>2022</year><month>Mar</month>;<volume>296</volume>:<fpage>114763</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.socscimed.2022.114763</pub-id><?supplied-pmid 35144225?><pub-id pub-id-type="pmid">35144225</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Choko</surname><given-names>AT</given-names></name>, <name><surname>Corbett</surname><given-names>EL</given-names></name>, <name><surname>Stallard</surname><given-names>N</given-names></name>, <name><surname>Maheswaran</surname><given-names>H</given-names></name>, <name><surname>Lepine</surname><given-names>A</given-names></name>, <name><surname>Johnson</surname><given-names>CC</given-names></name>, <etal>et al</etal>. <article-title>HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial</article-title>. <source>PLoS Med</source>. <year>2019</year><month>Jan</month>;<volume>16</volume>(<issue>1</issue>):<fpage>e1002719</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pmed.1002719</pub-id><?supplied-pmid 30601823?><pub-id pub-id-type="pmid">30601823</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Tanser</surname><given-names>FC</given-names></name>, <name><surname>Kim</surname><given-names>HY</given-names></name>, <name><surname>Mathenjwa</surname><given-names>T</given-names></name>, <name><surname>Shahmanesh</surname><given-names>M</given-names></name>, <name><surname>Seeley</surname><given-names>J</given-names></name>, <name><surname>Matthews</surname><given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Home-Based Intervention to Test and Start (HITS): a community-randomized controlled trial to increase HIV testing uptake among men in rural South Africa</article-title>. <source>J Int AIDS Soc</source>. <year>2021</year><month>Feb</month>;<volume>24</volume>(<issue>2</issue>):<fpage>e25665</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jia2.25665</pub-id><?supplied-pmid 33586911?><pub-id pub-id-type="pmid">33586911</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Barnabas</surname><given-names>RV</given-names></name>, <name><surname>van Heerden</surname><given-names>A</given-names></name>, <name><surname>McConnell</surname><given-names>M</given-names></name>, <name><surname>Szpiro</surname><given-names>AA</given-names></name>, <name><surname>Krows</surname><given-names>ML</given-names></name>, <name><surname>Schaafsma</surname><given-names>TT</given-names></name>, <etal>et al</etal>. <article-title>Lottery incentives have short-term impact on ART initiation among men: results from a randomized pilot study</article-title>. <source>J Int AIDS Soc</source>. <year>2020</year><month>Jun</month>;<volume>23</volume><issue>Suppl 2</issue>:<fpage>e25519</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/jia2.25519</pub-id><?supplied-pmid 32589342?><pub-id pub-id-type="pmid">32589342</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Unger</surname><given-names>T</given-names></name>, <name><surname>Borghi</surname><given-names>C</given-names></name>, <name><surname>Charchar</surname><given-names>F</given-names></name>, <name><surname>Khan</surname><given-names>NA</given-names></name>, <name><surname>Poulter</surname><given-names>NR</given-names></name>, <name><surname>Prabhakaran</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>2020 International Society of Hypertension Global Hypertension Practice Guidelines</article-title>. <source>Hypertension</source>. <year>2020</year><month>Jun</month>;<volume>75</volume>(<issue>6</issue>):<fpage>1334</fpage>–<lpage>57</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.120.15026</pub-id>
<?supplied-pmid 32370572?><pub-id pub-id-type="pmid">32370572</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Whelton Paul</surname><given-names>K.</given-names></name>, <name><surname>Carey Robert</surname><given-names>M.</given-names></name>, <name><surname>Aronow Wilbert</surname><given-names>S.</given-names></name>, <name><surname>Casey Donald</surname><given-names>E.</given-names></name>, <name><surname>Collins Karen</surname><given-names>J.</given-names></name>, <name><surname>Cheryl</surname><given-names>Dennison Himmelfarb</given-names></name>, <etal>et al</etal>. <article-title>2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</article-title>. <source>Hypertension</source>. <year>2018</year><month>Jun</month><day>1</day>;<volume>71</volume>(<issue>6</issue>):<fpage>e13</fpage>–<lpage>115</lpage>. <comment>DOI: </comment><pub-id pub-id-type="doi">10.1161/HYP.0000000000000066</pub-id>
<?supplied-pmid 29133354?><pub-id pub-id-type="pmid">29133356</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Gebresillassie</surname><given-names>BM</given-names></name>, <name><surname>Debay</surname><given-names>YB</given-names></name>. <article-title>Characteristics, treatment, and outcome of patients with hypertensive crisis admitted to University of Gondar Specialized Hospital, northwest Ethiopia: A cross-sectional study</article-title>. <source>J Clin Hypertens (Greenwich)</source>. <year>2020</year><month>Dec</month>;<volume>22</volume>(<issue>12</issue>):<fpage>2343</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="pmid">32966697</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Mandi</surname><given-names>DG</given-names></name>, <name><surname>Yaméogo</surname><given-names>RA</given-names></name>, <name><surname>Sebgo</surname><given-names>C</given-names></name>, <name><surname>Bamouni</surname><given-names>J</given-names></name>, <name><surname>Naibé</surname><given-names>DT</given-names></name>, <name><surname>Kologo</surname><given-names>KJ</given-names></name>, <etal>et al</etal>. <article-title>Hypertensive crises in sub-Saharan Africa: Clinical profile and short-term outcome in the medical emergencies department of a national referral hospital in Burkina Faso</article-title>. <source>Ann Cardiol Angeiol (Paris)</source>. <year>2019</year><month>Oct</month>;<volume>68</volume>(<issue>4</issue>):<fpage>269</fpage>–<lpage>74</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ancard.2019.07.007</pub-id>
<?supplied-pmid 31466723?><pub-id pub-id-type="pmid">31466723</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Mchomvu</surname><given-names>E</given-names></name>, <name><surname>Mbunda</surname><given-names>G</given-names></name>, <name><surname>Simon</surname><given-names>N</given-names></name>, <name><surname>Kitila</surname><given-names>F</given-names></name>, <name><surname>Temba</surname><given-names>Y</given-names></name>, <name><surname>Msumba</surname><given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Diagnoses made in an Emergency Department in rural sub-Saharan Africa</article-title>. <source>Swiss Med Wkly</source>. <year>2019</year><month>Jan</month><day>28</day>;<volume>149</volume>:<fpage>w20018</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4414/smw.2019.20018</pub-id><?supplied-pmid 30715723?><pub-id pub-id-type="pmid">30715723</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Mkoko</surname><given-names>P</given-names></name>, <name><surname>Naidoo</surname><given-names>S</given-names></name>, <name><surname>Niazi</surname><given-names>M</given-names></name>, <name><surname>Tahira</surname><given-names>A</given-names></name>, <name><surname>Godlwana</surname><given-names>X</given-names></name>, <name><surname>Ndesi</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>The spectrum, prevalence and in-hospital outcomes of cardiovascular diseases in a South African district hospital: a retrospective study</article-title>. <source>Cardiovasc J Afr</source>. <year>2021</year><month>Oct</month><day>23</day>;<volume>32</volume>(<issue>5</issue>):<fpage>237</fpage>–<lpage>42</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.5830/CVJA-2021-016</pub-id>
<?supplied-pmid 34128952?><pub-id pub-id-type="pmid">34128952</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Nakalema</surname><given-names>I</given-names></name>, <name><surname>Kaddumukasa</surname><given-names>M</given-names></name>, <name><surname>Nakibuuka</surname><given-names>J</given-names></name>, <name><surname>Okello</surname><given-names>E</given-names></name>, <name><surname>Sajatovic</surname><given-names>M</given-names></name>, <name><surname>Katabira</surname><given-names>E</given-names></name>. <article-title>Prevalence, patterns and factors associated with hypertensive crises in Mulago hospital emergency department; a cross-sectional study</article-title>. <source>Afr Health Sci</source>. <year>2019</year><month>Mar</month>;<volume>19</volume>(<issue>1</issue>):<fpage>1757</fpage>–<lpage>67</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.4314/ahs.v19i1.52</pub-id>
<?supplied-pmid 31149006?><pub-id pub-id-type="pmid">31149006</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Nkoke</surname><given-names>C</given-names></name>, <name><surname>Noubiap</surname><given-names>JJ</given-names></name>, <name><surname>Dzudie</surname><given-names>A</given-names></name>, <name><surname>M Jingi</surname><given-names>A</given-names></name>, <name><surname>Njume</surname><given-names>D</given-names></name>, <name><surname>Teuwafeu</surname><given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Epidemiology of hypertensive crisis in the Buea Regional Hospital, Cameroon</article-title>. <source>J Clin Hypertens (Greenwich)</source>. <year>2020</year><month>Nov</month>;<volume>22</volume>(<issue>11</issue>):<fpage>2105</fpage>–<lpage>10</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/jch.14035</pub-id>
<?supplied-pmid 32951311?><pub-id pub-id-type="pmid">32951311</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Reis</surname><given-names>KG</given-names></name>, <name><surname>Wilson</surname><given-names>R</given-names></name>, <name><surname>Kalokola</surname><given-names>F</given-names></name>, <name><surname>Wajanga</surname><given-names>B</given-names></name>, <name><surname>Lee</surname><given-names>MH</given-names></name>, <name><surname>Safford</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Hypertensive Urgency in Tanzanian Adults: A 1-Year Prospective Study</article-title>. <source>Am J Hypertens</source>. <year>2020</year><month>Dec</month><day>31</day>;<volume>33</volume>(<issue>12</issue>):<fpage>1087</fpage>–<lpage>91</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ajh/hpaa129</pub-id>
<?supplied-pmid 32776154?><pub-id pub-id-type="pmid">32776154</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277312.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Shao</surname><given-names>PJ</given-names></name>, <name><surname>Sawe</surname><given-names>HR</given-names></name>, <name><surname>Murray</surname><given-names>BL</given-names></name>, <name><surname>Mfinanga</surname><given-names>JA</given-names></name>, <name><surname>Mwafongo</surname><given-names>V</given-names></name>, <name><surname>Runyon</surname><given-names>MS</given-names></name>. <article-title>Profile of patients with hypertensive urgency and emergency presenting to an urban emergency department of a tertiary referral hospital in Tanzania</article-title>. <source>BMC Cardiovasc Disord</source>. <year>2018</year><month>Aug</month><day>2</day>;<volume>18</volume>(<issue>1</issue>):<fpage>158</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1186/s12872-018-0895-0</pub-id><?supplied-pmid 30068315?><pub-id pub-id-type="pmid">30068315</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
